Patent application number | Description | Published |
20090221699 | Fab I Inhibitors - Compounds are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections. | 09-03-2009 |
20090275572 | FAB I INHIBITORS - Compounds of the formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections. | 11-05-2009 |
20110098277 | Fab I Inhibitors - Compounds are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections. | 04-28-2011 |
20110190283 | Fab I Inhibitors - Compounds of the Formula (I) are disclosed which are Fab I inhibitors and are useful in the treatment of bacterial infections. | 08-04-2011 |
20110275611 | CHEMICAL COMPOUNDS - The invention is directed to 6-(4-pyrimidinyl)-1H-indazole derivatives. Specifically, the invention is directed to compounds according to Formula (I) wherein R | 11-10-2011 |
20130053383 | INDAZOLES - Herein are disclosed indazoles of formula (I) | 02-28-2013 |
20130053397 | INDOLES - Herein are disclosed indoles of formula (I) where the various groups are defined herein, and which are useful in treating cancer. | 02-28-2013 |
20130059849 | AZAINDAZOLES - Herein are disclosed azaindazoles of formula (I) | 03-07-2013 |
20130345200 | INDOLES - Herein are disclosed indoles of formula (I) | 12-26-2013 |
20140350013 | INDAZOLES - Herein are disclosed indazoles of formula (I) | 11-27-2014 |
Patent application number | Description | Published |
20080214549 | N-Substituted Glycine Derivatives: Hydroxylase Inhibitors - The invention described herein relates to certain pyridazinedione N-substituted glycine derivatives of formula (I) | 09-04-2008 |
20080234256 | Antibacterial Agents - Naphthyridine and related derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein. | 09-25-2008 |
20080293691 | Treatment Method - The present invention is directed to methods of treating an ocular neovascular disorder in a mammal by administration of pyrimidine derivatives, benzodiazepinyl derivatives and pharmaceutical compositions containing the same. The invention encompasses methods of treating an ocular neovascular disorder by administration of 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide, (S)-3-oxo-8-[3-(pyridin-2-ylamino)-1-propyloxy]-2-(2,2,2-trifluoroethyl)-2,3,4,5-tetrahydro-1H-2-benzazepine-4-acetic acid or salts or solvates thereof. Combination therapies for the treatment of ocular neovascular disorders are also encompassed. | 11-27-2008 |
20090054418 | Antibacterial Agents - 2H-chromen-2-one derivatives useful in the treatment of bacterial infections in mammals, particularly humans, are disclosed herein. | 02-26-2009 |
20100081650 | Antimicrobial Compounds - Cyclohexane and cyclohexene derivatives and pharmaceutically acceptable derivatives thereof useful in methods of treatment of bacterial infections in mammals, particularly man. | 04-01-2010 |
20130245016 | INDOLES - Herein are disclosed indoles of formula (I) | 09-19-2013 |
20140343056 | AZAINDAZOLES - Herein are disclosed azaindazoles of formula (I) | 11-20-2014 |